Newsroom

[WSJ] Will Gilead’s Hepatitis C Drug Bust State Budgets?

Will the cost of new hepatitis C treatments bust state budgets? A new analysis suggests many states may, in fact, be overwhelmed as they attempt to […]

Read more

[NCHC] Where is the Value in Overpricing Innovative Treatments?

At $1,000 per pill, the price of the new hepatitis C drug Sovaldi has generated much attention. It’s certainly a breakthrough drug and the type of […]

Read more

[USA Today] Why $1,000 a pill? Our view

In the good-news/bad-news world of blockbuster drugs, the latest is the launch of Sovaldi, a drug to treat hepatitis C. Sovaldi comes with a cure rate […]

Read more

[The Hill] Poll: 4 in 5 say $1,000-a-pill drug cost ‘unacceptable’

Eighty-two percent in a new poll say the cost of a $1,000-a-pill medicine which has sparked congressional scrutiny is “unacceptable” and expressed concerns the specialty drug […]

Read more